Mohammad Hossein Asghari

6PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Proteins and peptidesFoetal development and medicinePredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 01, 2026
Efficacy and safety of atezolizumab combined with bevacizumab-based chemotherapy in advanced malignancies: a systematic review and meta-analysis of randomized trials.

Kimia Pakdaman, Amirhossein Alizadeh-Nodehi, Amin Esmaeilnia Shirvani

|Mar 08, 2023
Virtual screening reveals aprepitant to be a potent inhibitor of neutral sphingomyelinase 2: implications in blockade of exosome release in cancer therapy.

Milad Moloudizargari, Shirin Hekmatirad, Sajjad Gharaghani

|May 09, 2022
Protective Effect of Melatonin on Nonylphenol-Induced Reproductive and Behavioral Disorders in First-Generation Adult Male Rats.

Mahsa Tavakoli, Ali Akbar Moghadamnia, Fereshteh Pourabdolhossein

|Dec 13, 2021
The prognostic role of miR-31 in colorectal cancer: the results of a meta-analysis of 4720 patients.

Milad Moloudizargari, Jamal Rahmani, Mohammad Hossein Asghari

|Sep 06, 2020
The mechanisms of cellular crosstalk between mesenchymal stem cells and natural killer cells: Therapeutic implications.

Milad Moloudizargari, Ali Govahi, Marjan Fallah

|Jul 05, 2019
Immunoregulatory role of melatonin in cancer.

Fatemeh Moradkhani, Milad Moloudizargari, Marjan Fallah

Pageof 1

Frequent Collaborators

2 joint publications

Milad Moloudizargari

1 joint publications

Mohammad Abdollahi

1 joint publications

Heidar Heidari Khoei

1 joint publications

Jamal Rahmani